Literature DB >> 15986855

Acute pancreatitis in patients with ulcerative colitis.

Hidekazu Inoue1, Katsuya Shiraki, Hiroshi Okano, Masatoshi Deguchi, Takenari Yamanaka, Takahisa Sakai, Shigeru Ohmori, Hitoshi Yoshimura, Takeshi Nakano.   

Abstract

Twenty-two patients (13 men and 9 women; median age, 34 years; range, 15-64 years) with ulcerative colitis (UC) were evaluated to determine the incidence of acute pancreatitis with UC at the First Department of Internal Medicine, Mie University School of Medicine, during 1989-2001. Among these, three patients (14%) were diagnosed as having had episodes of acute pancreatitis during the mean follow-up period of 6 years. One patient presented with acute pancreatitis and UC simultaneously. Two patients had drug-induced pancreatitis (one due to azathioprine and the other due to 5-ASA). In conclusion, acute pancreatitis is not a frequent, but an occasional extraintestinal manifestation of UC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986855     DOI: 10.1007/s10620-005-2705-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease.

Authors:  B Heikius; S Niemelä; J Lehtola; T J Karttunen
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

Review 2.  Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.

Authors:  E Adachi; K Okazaki; Y Matsushima; H Seno; K Uchida; H Nakase; C Kawanami; T Nakamura; T Chiba
Journal:  Int J Pancreatol       Date:  1999-06

3.  Azathioprine-related pancreatitis in patients with Crohn's disease.

Authors:  R A Sturdevant; J W Singleton; J L Deren; D H Law; J L McCleery
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

4.  Chronic pancreatitis associated with ulcerative colitis.

Authors:  D Forbes; R B Scott; C Trevenen; N Hershfield; D G Gall
Journal:  Clin Invest Med       Date:  1987-07       Impact factor: 0.825

Review 5.  Drug-induced pancreatitis: a critical review.

Authors:  A Mallory; F Kern
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

6.  The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  O Epstein; R W Chapman; G Lake-Bakaar; A Y Foo; S B Rosalki; S Sherlock
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

7.  Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors:  J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

8.  HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease.

Authors:  E Schrumpf; O Fausa; O Førre; J H Dobloug; S Ritland; E Thorsby
Journal:  Scand J Gastroenterol       Date:  1982-03       Impact factor: 2.423

9.  Pancreatic insufficiency associated with ulcerative colitis and pericholangitis.

Authors:  L E Gurian; E B Keeffe
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

10.  Drug induced acute pancreatitis: incidence and severity.

Authors:  P G Lankisch; M Dröge; F Gottesleben
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  3 in total

1.  Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease.

Authors:  Geum-Chae-Won Yi; Ka-Hyun Yoon; Jin-Bok Hwang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2012-12-31

2.  Clinical course of ulcerative colitis patients who develop acute pancreatitis.

Authors:  Jong Wook Kim; Sung Wook Hwang; Sang Hyoung Park; Tae Jun Song; Myung-Hwan Kim; Ho-Su Lee; Byong Duk Ye; Dong-Hoon Yang; Kyung-Jo Kim; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

3.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.